Intranasal Insulin for the Treatment of Mild Cognitive Impairment and Alzheimer Disease Dementia

Release Date:

Interview with Suzanne Craft, PhD, author of Safety, Efficacy, and Feasibility of Intranasal Insulin for the Treatment of Mild Cognitive Impairment and Alzheimer Disease Dementia: A Randomized Clinical Trial

Intranasal Insulin for the Treatment of Mild Cognitive Impairment and Alzheimer Disease Dementia

Title
Intranasal Insulin for the Treatment of Mild Cognitive Impairment and Alzheimer Disease Dementia
Copyright
Release Date

flashback